Lucera Erick Sells Dyne Therapeutics Stock

Erick Lucera, Chief Financial Officer of Dyne Therapeutics, Inc., sold 2,362 shares of common stock on June 25, 2026. The sale was conducted at a weighted average price of $20.37 per share, with individual transactions ranging from $20.33 to $20.68. This sale was to cover tax obligations incurred from the vesting of restricted stock units. Following this transaction, Lucera holds 121,563 shares, which includes 110,513 unvested restricted stock units.